Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alx Oncology Holdings Inc 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 USA

www.alxoncology.com Employees: 80 P: 650-466-7125

Sector:

Medical

Description:

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Key Statistics

Overview:

Market Capitalization, $K 73,736
Enterprise Value, $K 66,076
Shares Outstanding, K 54,218
Annual Sales, $ 0 K
Annual Net Income, $ -134,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -22,140 K
EBIT, $ -111,610 K
EBITDA, $ -115,130 K
60-Month Beta 0.53
% of Insider Shareholders 21.00%
% of Institutional Shareholders 97.97%
Float, K 42,832
% Float 79.00%
Short Interest 794
Short Float 1.46%
Short Volume Ratio 0.21

Growth:

1-Year Return -25.68%
3-Year Return -87.93%
5-Year Return -98.42%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 11/07/25
Next Earnings Date 03/05/26
Earnings Per Share ttm -2.03
EPS Growth vs. Prev Qtr 16.33%
EPS Growth vs. Prev Year 29.31%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ALXO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -138.86%
Return-on-Assets % -96.71%
Profit Margin % 0.00%
Debt/Equity 0.23
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.67
Book Value/Share 0.84
Interest Coverage -76.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar